WHO ICTRP trial
A multicenter, double-blind, randomized, placebo-controlled trial for the effect…
ChiCTR1900026614 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900026614 |
|---|---|
| Public title | A multicenter, double-blind, randomized, placebo-controlled trial for the effect of traditional Chinese medicine formula Dingkun pill on improving outcomes of IVF-ET in women with low prognosis |
| Scientific title | A multicenter, double-blind, randomized, placebo-controlled trial for the effect of traditional Chinese medicine formula Dingkun pill on improving outcomes of IVF-ET in women with low prognosis |
| Primary sponsor | The Affiliated Hospital of Shandong University of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Low prognosis |
| Interventions | DKP group:Dingkun pill should be administered on the 5th day of the menstrual cycle prior to controlled ovarian stimulation (COH), 7g each time, 3 times per day, until the oocyte retrieval day, a total of 5 weeks.;Placebo group:Placebo… |
| Registration date | Oct 16, 2019 |
| Target size | DKP group:230;Placebo group:230 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: